姓　名：胡艳霞

          职　称：讲师

          导师类别：硕士生导师

          E-mail: huyanxia2024@hainanu.edu.cn

一、个人基本情况

胡艳霞，女，博士，硕士生导师，永利集团高层次引进人才

二、教育工作情况

2012-2017，重庆医科大学，医学检验，学士

2017-2020，重庆医科大学，临床检验诊断学，硕士

2020-2023，中山大学，基础医学，博士

三、科研情况

以第一作者（包括共同）在Nature Communications，Advanced Science和HEPATOLOGY上发表论文3篇。

四、研究领域

主要从事RNA修饰响应环境刺激、调控健康稳态、参与疾病发生发展的作用机制研究。

五、代表性成果

1. Yanxia Hu#, Liting Diao#, Yarui Hou#, Guo Lv, Shuang Tao, Wanyi Xu, Shujuan Xie, Yahan Ren, and Zhendong Xiao*. PUS1 promotes hepatocellular carcinoma via mRNA pseudouridylation to enhance the translation of oncogenic mRNAs. HEPATOLOGY (Baltimore, Md). 2023; 10.1097/hep.0000000000000702.

2. Yarui Hou#, Liting Diao#, Yanxia Hu#, Qianqian Zhang, Guo Lv, Shuang Tao, Wanyi Xu, Shujuan Xie*, Qi Zhang*, and Zhendong Xiao*, The Conserved LncRNA DIO3OS Restricts Hepatocellular Carcinoma Stemness by Interfering with NONO-Mediated Nuclear Export of ZEB1 mRNA. Advanced Science (Weinh), 2023: p.e2301983.

3. Yajun Xie#, Xiaoyan Lv#, Dongsheng Ni#, Jianing Liu#, Yanxia Hu#, Yamin Liu#, Yunhong Liu, Rui Liu, Hui Zhao and Zhimin Lu*, Qin Zhou*. HPD degradation regulated by the TTC36-STK33-PELI1 signaling axis induces tyrosinemia and neurological damage. Nature Communications. 2019;10(1):4266.